Rhinosinusitis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
Current literature suggests that in patients with refractory chronic rhinosinusitis endoscopic sinus surgery is superior to continued medical therapy in terms of symptom relief, quality of life and cost effectiveness. In patients with less sever forms of the disease, medical therapy is more cost effective, since it helps maintain the quality of life and health-state utility of the patients.<ref name="pmid27863163">{{cite journal| author=Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang PH| title=Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis. | journal=Int Forum Allergy Rhinol | year= 2017 | volume= 7 | issue= 2 | pages= 119-127 | pmid=27863163 | doi=10.1002/alr.21872 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27863163 }} </ref> | Current literature suggests that in patients with refractory chronic rhinosinusitis endoscopic sinus surgery is superior to continued medical therapy in terms of symptom relief, quality of life and cost effectiveness. In patients with less sever forms of the disease, medical therapy is more cost effective, since it helps maintain the quality of life and health-state utility of the patients.<ref name="pmid27863163">{{cite journal| author=Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang PH| title=Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis. | journal=Int Forum Allergy Rhinol | year= 2017 | volume= 7 | issue= 2 | pages= 119-127 | pmid=27863163 | doi=10.1002/alr.21872 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27863163 }} </ref> | ||
Revision as of 11:03, 5 December 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Cost-effectiveness of Therapy
Current literature suggests that in patients with refractory chronic rhinosinusitis endoscopic sinus surgery is superior to continued medical therapy in terms of symptom relief, quality of life and cost effectiveness. In patients with less sever forms of the disease, medical therapy is more cost effective, since it helps maintain the quality of life and health-state utility of the patients.[1]
References
- ↑ Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang PH (2017). "Surgical therapy vs continued medical therapy for medically refractory chronic rhinosinusitis: a systematic review and meta-analysis". Int Forum Allergy Rhinol. 7 (2): 119–127. doi:10.1002/alr.21872. PMID 27863163.